Related Experiment Video
Updated: Jan 24, 2026

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery
Published on: June 7, 2024
Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy
Fabio Cofano1, Marina Boido2, Matteo Monticelli3
1Department of Neuroscience "Rita Levi Montalcini", Neurosurgery Unit, University of Turin, 10126 Turin, Italy. fabio.cofano@unito.it.
Abstract:
Spinal cord injury (SCI) constitutes an inestimable public health issue. The most crucial phase in the pathophysiological process of SCI concerns the well-known secondary injury, which is the uncontrolled and destructive cascade occurring later with aberrant molecular signaling, inflammation, vascular changes, and secondary cellular dysfunctions. The use of mesenchymal stem cells (MSCs) represents one of the most important and promising tested strategies. Their appeal, among the other sources and types of stem cells, increased because of their ease of isolation/preservation and their properties. Nevertheless, encouraging promise from preclinical studies was followed by weak and conflicting results in clinical trials. In this review, the therapeutic role of MSCs is discussed, together with their properties, application, limitations, and future perspectives.
Insights
Mesenchymal stem cells (MSCs) show promise for treating spinal cord injury (SCI) by mitigating secondary injury cascades. However, clinical trial results remain inconsistent, necessitating further research into MSCs
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Therapy
Background:
- Spinal cord injury (SCI) is a significant public health concern.
- Secondary injury involves a destructive cascade of inflammation and cellular dysfunction.
- Mesenchymal stem cells (MSCs) are a promising therapeutic strategy due to their properties and ease of use.
Purpose of the Study:
- To review the therapeutic potential of MSCs for SCI.
- To discuss MSC properties, applications, and limitations.
- To explore future perspectives for MSC-based SCI treatment.
Main Methods:
- Literature review of preclinical and clinical studies on MSCs for SCI.
- Analysis of MSC characteristics relevant to SCI.
- Evaluation of current applications and challenges.
Main Results:
- Preclinical studies show encouraging results for MSCs in SCI.
- Clinical trials have yielded weak and conflicting outcomes.
- MSC properties offer potential benefits but face limitations.
Conclusions:
- MSCs hold therapeutic promise for SCI, particularly in managing secondary injury.
- Translating preclinical success to clinical efficacy requires further investigation.
- Future research should focus on optimizing MSC application and overcoming current limitations.
More Related Videos
Related Concept Videos
Mesenchymal Stem Cells
Spinal Cord
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
The Spinal Cord
Adult Stem Cells
Spinal Cord: Information Processing
Sensory Information Processing
Sensory information processing begins at the sensory receptors located in the skin and other tissues, which detect somatic sensory stimuli such as touch, temperature, or pain. These receptors function as catalysts, initiating...

